Impact of a 21-valent pneumococcal conjugate vaccine on pneumococcal disease incidence among adults 65-84 years of age in Belgium: An epidemiological modeling study. [PDF]
Vandenplas Y +6 more
europepmc +1 more source
Inequalities in childhood pneumococcal conjugate vaccine uptake in England before and after the change from a 2 + 1 to 1 + 1 schedule: a longitudinal study. [PDF]
Ilechukwu P +3 more
europepmc +1 more source
Impact of Pneumococcal Conjugate Vaccine Immunization on Nasopharyngeal Carriage of <i>Streptococcus pneumoniae</i> in Vaccinated Children Under 5 Years Old in El Salvador. [PDF]
Dueñas ML +10 more
europepmc +1 more source
Safety and immunogenicity of 13-Valent pneumococcal conjugate vaccine in healthy infants in Shanghai during the COVID-19 pandemic: a prospective cohort study. [PDF]
Xin L, Hong L, Wang S, Qian X, Li Y.
europepmc +1 more source
The mutual effects on safety and immunogenicity of combined vaccination with 15-valent pneumococcal conjugate vaccine and adsorbed acellular DPT in 3-month healthy infants: A randomized, open-label, controlled, phase III clinical trial. [PDF]
Lu-Lu P +13 more
europepmc +1 more source
Long-term impact of the 10-valent pneumococcal conjugate vaccine on nonvaccine pneumococcal serotypes: implications for practice and surveillance. [PDF]
Brum M +9 more
europepmc +1 more source
Efficacy, immunogenicity, and safety of pneumococcal conjugate vaccine in children: a systematic review and meta-analysis. [PDF]
Dai Q, Dong Y, Wu J, Peng Q.
europepmc +1 more source
Chronicling the Journey of Pneumococcal Conjugate Vaccine Introduction in India. [PDF]
Kumar P +11 more
europepmc +1 more source

